We are live on ! Find out more
BCM

Blume Capital Management Portfolio holdings

AUM $684M
1-Year Est. Return 41.68%
This Fund
S&P 500
This Quarter Est. Return
-14.36%
1 Year Est. Return
+41.68%
3 Year Est. Return
+96.87%
5 Year Est. Return
+108.87%
10 Year Est. Return
+366.52%
AUM
$175M
AUM Growth
-$16.3M
Cap. Flow
+$16.6M
Cap. Flow %
9.48%
Top 10 Hldgs %
41.71%
Holding
233
New
33
Increased
27
Reduced
41
Closed
7

Top Sells

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$2.71M
2
WY icon
Weyerhaeuser
WY
+$2.43M
3
WMB icon
Williams Companies
WMB
+$1.75M
4
OAK
OAKTREE CAPITAL GROUP, LLC
OAK
+$1.61M
5
GE icon
GE Aerospace
GE
+$1.53M

Sector Composition

Rank Sector Weight
1 Technology 17.99%
2 Financials 15.46%
3 Communication Services 11.62%
4 Healthcare 10.58%
5 Energy 7.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHG icon
151
Schwab US Large-Cap Growth ETF
SCHG
$61.1B
$28K 0.02%
3,200
-3,272
-51% -$30.5K
CLX icon
152
Clorox
CLX
$11.8B
$27K 0.02%
175
-75
-30% -$11.7K
FTV icon
153
Fortive
FTV
$18B
$27K 0.02%
634
GIS icon
154
General Mills
GIS
$19.2B
$27K 0.02%
700
WMB icon
155
Williams Companies
WMB
$86.1B
$27K 0.02%
1,225
-70,150
-98% -$1.75M
REZI icon
156
Resideo Technologies
REZI
$5.4B
$25K 0.01%
+1,234
New +$26.3K
ROST icon
157
Ross Stores
ROST
$80.9B
$25K 0.01%
300
VMBS icon
158
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
$25K 0.01%
477
BABA icon
159
Alibaba
BABA
$307B
$24K 0.01%
175
BMRN icon
160
BioMarin Pharmaceuticals
BMRN
$11.6B
$23K 0.01%
+270
New +$25.7K
TEL icon
161
TE Connectivity
TEL
$58.4B
$23K 0.01%
+300
New +$23.1K
PTLA
162
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$20K 0.01%
1,000
AABA
163
DELISTED
Altaba Inc
AABA
$20K 0.01%
350
AZN icon
164
AstraZeneca
AZN
$244B
$19K 0.01%
+250
New +$19.5K
HP icon
165
Helmerich & Payne
HP
$3.39B
$19K 0.01%
400
VO icon
166
Vanguard Morningstar Mid-Cap ETF
VO
$107B
$19K 0.01%
556
BXP icon
167
Boston Properties
BXP
$11.3B
$18K 0.01%
164
-24
-13% -$2.91K
EUFN icon
168
iShares MSCI Europe Financials ETF
EUFN
$4.23B
$17K 0.01%
+1,000
New +$18.4K
NVS icon
169
Novartis
NVS
$291B
$17K 0.01%
223
VNO icon
170
Vornado Realty Trust
VNO
$7.5B
$16K 0.01%
257
BP icon
171
BP
BP
$114B
$15K 0.01%
+413
New +$16.5K
DRRX
172
DELISTED
DURECT Corp
DRRX
$15K 0.01%
3,100
EMN icon
173
Eastman Chemical
EMN
$8.22B
$15K 0.01%
200
FATE icon
174
Fate Therapeutics
FATE
$291M
$15K 0.01%
+1,200
New +$16.7K
NKX icon
175
Nuveen California AMT-Free Quality Municipal Income Fund
NKX
$648M
$15K 0.01%
1,200

Similar funds

Blume Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Blume Capital Management held 233 positions worth $175M, down 8.5% from $191M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Blume Capital Management deployed $16.6M of net new capital in Q4 2018, opening 33 new positions and adding to 27 existing holdings. Its largest new stake was Schwab International Equity ETF: 323,650 shares worth $4.59M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 22% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was SLB Ltd, an estimated $2.71M trimmed.

  • Blume Capital Management's largest Q4 2018 buy was Schwab International Equity ETF: 323,650 shares worth $4.59M.
  • Blume Capital Management added most to Schwab Short-Term US Treasury ETF in Q4 2018, an estimated $4.75M increase.
  • Blume Capital Management's biggest Q4 2018 reduction was SLB Ltd, cutting an estimated $2.71M.
  • Blume Capital Management fully exited Highwoods Properties in Q4 2018, selling an estimated $35K.
  • Blume Capital Management's ten largest holdings make up 42% of its $175M portfolio in Q4 2018.
  • Blume Capital Management opened 33 new positions and closed 7 in Q4 2018.
  • Blume Capital Management's portfolio value fell 8.5% quarter-over-quarter to $175M.

Based on Blume Capital Management's 13F filing for Q4 2018, filed 5 Feb 2019.